Primary Recipient

INVASC THERAPEUTICS, INC.

Amount

$199,932.00

Award Date

5/17/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Cardiovascular diseases are the number one killer around the world. Myeloperoxidase enzyme (MPO) has been implicated in many cardiovascular diseases but there are no MPO inhibitor drugs available for treatment. The development of novel therapy for MPO e

Recipients Connected to Award

Recipient	Role	Amount
INVASC THERAPEUTICS, INC.	Primary recipient	$108,288.00
OHIO STATE UNIVERSITY, THE	Sub-recipient	$91,644.00